Amgen's Blincyto Data Send Cullinan Higher
Seeking AlphaApr 27 15:39 ET
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceApr 27 10:29 ET
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
TipRanksApr 27 00:20 ET
Gilead Sciences To Go Ex-Dividend On June 14th, 2024 With 0.77 USD Dividend Per Share
April 27th - $Gilead Sciences(GILD.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.77 USD dividend per share on June 27th, 2024. The ex-div
moomoo NewsApr 26 19:40 ET
Options Corner: Gilead Sciences Sees Deep-Pocketed Investors Take Bullish Stance
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:GILD), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga un
BenzingaApr 26 15:45 ET
Gilead Sciences Price Target Cut to $85.00/Share From $90.00 by TD Cowen
Gilead Sciences Price Target Cut to $85.00/Share From $90.00 by TD Cowen
Dow JonesApr 26 13:35 ET
Gilead Sciences Is Maintained at Sector Perform by RBC Capital
Gilead Sciences Is Maintained at Sector Perform by RBC Capital
Dow JonesApr 26 11:57 ET
Express News | RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $74
BenzingaApr 26 11:46 ET
Gilead Sciences Declares $0.77 Dividend
Seeking AlphaApr 26 10:26 ET
Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80
Gilead Sciences (GILD) has an average rating of outperform and price targets ranging from $69 to $121, according to analysts polled by Capital IQ. Price: 64.76, Change: -0.51, Percent Change: -0.78
MT NewswiresApr 26 09:59 ET
Earnings Call Summary | Gilead Sciences(GILD.US) Q1 2024 Earnings Conference
The following is a summary of the Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript:Financial Performance:Gilead's Q1 total product sales, excluding Veklury, grew 6% year-over-year to $6.1
moomoo AIApr 26 09:13 ET · Conference Call
Analysts Are Bullish on Top Healthcare Stocks: Regeneron (REGN), Gilead Sciences (GILD)
TipRanksApr 26 08:21 ET
Express News | Gilead - Biktarvy Label Includes Boxed Warning for Post Treatment Acute Exacerbation of Hepatitis B
ReutersApr 26 08:02 ET
Express News | FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With Hiv
ReutersApr 26 08:00 ET
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Globus Medical (GMED) and Merck & Company (MRK)
TipRanksApr 26 06:30 ET
Express News | Needham Reiterates Hold on Gilead Sciences
BenzingaApr 26 06:21 ET
Gilead Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/26/2024 — Needham Reiterates → Hold 04/24/2024 5.91% HSBC → $69 Upgrades Reduce → Hold 04/19/2024 61.1
BenzingaApr 26 06:19 ET
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Yahoo FinanceApr 26 03:35 ET
Express News | Gilead : TD Cowen Cuts Target Price to $85 From $90
ReutersApr 26 01:56 ET
Express News | Gilead : Jefferies Cuts Target Price to $80 From $95
ReutersApr 26 01:24 ET
No Data
No Data